outcomes | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

outcomes

Amoxicillin for acute rhinosinusitis: a randomized controlled trial.

Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. 2012;307(7):685-92. doi:10.1001/jama.2012.138.

Stiff-man syndrome and variants: clinical course, treatments, and outcomes.

McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012;69(2):230-8. doi:10.1001/archneurol.2011.991.

Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.

Seshasai SRK, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(3):209-16. doi:10.1001/archinternmed.2011.628.

Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".

Mora S. Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes". Arch Intern Med. 2012;172(3):217-8. doi:10.1001/archinternmed.2011.626.

Improving Alzheimer's disease outcomes in Down's syndrome

Livingston G, Strydom A. Improving Alzheimer's disease outcomes in Down's syndrome. The Lancet. 2012;379(9815):498 - 500. doi:10.1016/S0140-6736(11)61929-6.

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review.

Mah GT, Mabasa VH, Chow I, Ensom MHH. Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother. 2012;46(2):265-75. doi:10.1345/aph.1Q378.

Rosiglitazone, myocardial ischemic risk, and recent regulatory actions.

Bourg CA, Phillips BB. Rosiglitazone, myocardial ischemic risk, and recent regulatory actions. Ann Pharmacother. 2012;46(2):282-9. doi:10.1345/aph.1Q400.

Nocebo effects, patient-clinician communication, and therapeutic outcomes.

Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567-8. doi:10.1001/jama.2012.115.

Midwifery ratios might explain some differences in perinatal and maternal outcomes

Falconer A, Walker J, Richmond D, Kilby M. Midwifery ratios might explain some differences in perinatal and maternal outcomes. BMJ. 2012;344(feb07 3):e891 - e891. doi:10.1136/bmj.e891.

So what? Does the test lead to improved health outcomes?

Michelson DJ, Shevell MI, Sherr EH, et al. So what? Does the test lead to improved health outcomes?. Neurology. 2012;78(6):440-1; author reply 441-2. doi:10.1212/WNL.0b013e318248042c.